Source: PR Newswire

Press Release: Specialty Enzymes & Biotechnologies : SEBiotic Receives No Objections Letter from FDA for GRAS Submission

CHINO, Calif., Feb. 23, 2021 /PRNewswire/ -- Specialty Enzymes & Probiotics is proud to announce SEBiotic received a No Objections Letter from the FDA for its GRAS, which stands for Generally Recognized As Safe, submission. The GRAS Notification Program is a voluntary submission for...

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
100-250
Vic Rathi's photo - President & CEO of SEB

President & CEO

Vic Rathi

CEO Approval Rating

81/100

Read more